1 |
Ricardi U, Frezza G, Filippi AR, et al. Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: an Italian multicenter observational study. Lung cancer 84(3):248-53 (2014).
DOI
|
2 |
Song SY, Choi W, Shin SS, et al. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus. Lung cancer 66(1):89-93 (2009).
DOI
|
3 |
Matsuo Y, Chen F, Hamaji M, et al. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis. European journal of cancer 50(17):2932-8 (2014).
DOI
|
4 |
Port JL, Parashar B, Osakwe N, et al. A propensity matched analysis of wedge resection and stereotactic body radiotherapy for early stage lung cancer. The Annals of thoracic surgery 98(4):1152-9 (2014).
DOI
|
5 |
Zhang B, Zhu F, Ma X, et al. Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: a systematic review and meta-analysis. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 112(2):250-5 (2014).
DOI
|
6 |
Kestin L, Grills I, Guckenberger M, et al. Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 110(3):499-504 (2014).
DOI
|
7 |
Koshy M, Malik R, Weichselbaum RR, Sher DJ. Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer. International journal of radiation oncology, biology, physics 91(2):344-50 (2015).
DOI
|
8 |
Matsuo Y, Shibuya K, Nakamura M, et al. Dose--volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer. International journal of radiation oncology, biology, physics 83(4):e545-9 (2012).
DOI
|
9 |
Asai K, Shioyama Y, Nakamura K, et al. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy: risk factors and dose-volume relationship. International journal of radiation oncology, biology, physics 84(3):768-73 (2012).
DOI
|
10 |
Dunlap NE, Cai J, Biedermann GB, et al. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. International journal of radiation oncology, biology, physics 76(3):796-801 (2010).
DOI
|
11 |
Bhatt AD, El-Ghamry MN, Dunlap NE, et al. Tumor volume change with stereotactic body radiotherapy (SBRT) for early-stage lung cancer: evaluating the potential for adaptive SBRT. American journal of clinical oncology 38(1):41-6 (2015).
DOI
|
12 |
Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 24(30):4833-9 (2006).
DOI
|
13 |
Erridge SC, Seppenwoolde Y, Muller SH, et al. Portal imaging to assess set-up errors, tumor motion and tumor shrinkage during conformal radiotherapy of non-small cell lung cancer. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology 66(1):75-85 (2003).
DOI
|
14 |
Siker ML, Tome WA, Mehta MP. Tumor volume changes on serial imaging with megavoltage CT for non-small-cell lung cancer during intensity-modulated radiotherapy: how reliable, consistent, and meaningful is the effect? International journal of radiation oncology, biology, physics 66(1):135-41 (2006).
DOI
|
15 |
Gunter T, Ali I, Matthiesen C, et al. Gross tumour volume variations in primary non-small-cell lung cancer during the course of treatment with stereotactic body radiation therapy. Journal of medical imaging and radiation oncology 58(3):384-91 (2014).
DOI
|
16 |
Saito AI, Olivier KR, Li JG, et al. Lung tumor motion change during stereotactic body radiotherapy (SBRT): an evaluation using MRI. Journal of applied clinical medical physics / American College of Medical Physics, 15(3):4434 (2014).
|
17 |
Bral S, Duchateau M, De Ridder M, et al. Volumetric response analysis during chemoradiation as predictive tool for optimizing treatment strategy in locally advanced unresectable NSCLC. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology 91(3):438-42 (2009).
DOI
|
18 |
Tatekawa K, Iwata H, Kawaguchi T, et al. Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy. Radiation oncology 9:8 (2014).
DOI
|
19 |
Yi BS, Perks J, Houston R, et al. Changes in position and volume of lung cancer target volumes during stereotactic body radiotherapy (SBRT): is image guidance necessary? Technology in cancer research & treatment 10(5):495-504 (2011).
DOI
|
20 |
Feng M, Kong FM, Gross M, et al. Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing. International journal of radiation oncology, biology, physics 73(4):1228-34 (2009).
DOI
|
21 |
Britton KR, Starkschall G, Tucker SL, et al. Assessment of gross tumor volume regression and motion changes during radiotherapy for non-small-cell lung cancer as measured by four-dimensional computed tomography. International journal of radiation oncology, biology, physics 68(4):1036-46 (2007).
DOI
|
22 |
Kupelian PA, Ramsey C, Meeks SL, et al. Serial megavoltage CT imaging during external beam radiotherapy for non-small- cell lung cancer: observations on tumor regression during treatment. International journal of radiation oncology, biology, physics 63(4):1024-8 (2005).
DOI
|
23 |
Barriger RB, Forquer JA, Brabham JG, et al. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy. International journal of radiation oncology, biology, physics 82(1): 457-62 (2012).
DOI
|
24 |
Westhoff PG, de Graeff A, Geerling JI, Reyners AK, van der Linden YM. Dexamethasone for the prevention of a pain flare after palliative radiotherapy for painful bone metastases: a multicenter double-blind placebo-controlled randomized trial. BMC cancer 14:347 (2014).
DOI
|
25 |
Pan HY, Allen PK, Wang XS, et al. Incidence and predictive factors of pain flare after spine stereotactic body radiation therapy: secondary analysis of phase 1/2 trials. International journal of radiation oncology, biology, physics 90(4):870-6 (2014).
DOI
|
26 |
Shirata Y, Jingu K, Koto M, et al. Prognostic factors for local control of stage I non-small cell lung cancer in stereotactic radiotherapy: a retrospective analysis. Radiation oncology 7:182 (2012).
DOI
|
27 |
Yoo S, Yin FF. Dosimetric feasibility of cone-beam CT-based treatment planning compared to CT-based treatment planning. International journal of radiation oncology, biology, physics 66(5):1553-61 (2006).
DOI
|
28 |
Yang Y, Schreibmann E, Li T, Wang C, Xing L. Evaluation of on-board kV cone beam CT (CBCT)-based dose calculation. Physics in medicine and biology 52(3):685-705 (2007).
DOI
|
29 |
Altorjai G, Fotina I, Lutgendorf-Caucig C, et al. Cone-beam CT-based delineation of stereotactic lung targets: the influence of image modality and target size on interobserver variability. International journal of radiation oncology, biology, physics 82(2): e265-72 (2012).
DOI
|
30 |
Guckenberger M, Richter A, Wilbert J, Flentje M, Partridge M. Adaptive radiotherapy for locally advanced non-small-cell lung cancer does not underdose the microscopic disease and has the potential to increase tumor control. International journal of radiation oncology, biology, physics 81(4):e275-82 (2011).
DOI
|